OpenAlex
PricingAboutJobs
Log inGet started
Work

[Semaglutide, once weekly GLP-1 receptor agonist (Ozempic®)].

PubMed

Year: 2019
Type: article
Source: PubMed
Author: A J Scheen
Institution: Centre Hospitalier Universitaire de Liège
Language: French

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: semaglutide, Ozempic, GLP-1 receptor agonists, type 2 diabetes, glucose-lowering efficacy, weight loss, SUSTAIN trials, subcutaneous injection, metformin failure, drug reimbursement, obesity
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2994626215
FWCI: 0.123
Cites:
Cited by: 7
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security